Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy

This study has been completed.

Study NCT00568035 Information provided by Quigley Pharma, Inc.

First Received: December 3, 2007 Last Updated: January 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2008
Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)